USE OF LINAGLIPTIN IN CARDIO- AND RENOPROTECTIVE ANTIDIABETIC THERAPY Application EP-4364796-A3 European Patent Office 24 Jul 2024
CARDIO- AND RENOPROTECTIVE ANTIDIABETIC THERAPY Application EA-037712-B1 Eurasian Patent Organisation 13 May 2021
USE OF LINAGLIPTIN IN CARDIO- AND RENOPROTECTIVE ANTIDIABETIC THERAPY Application EP-3744327-A1 European Patent Office 02 Dec 2020